HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melanoma cell CD44 interaction with the alpha 1(IV)1263-1277 region from basement membrane collagen is modulated by ligand glycosylation.

Abstract
Invasion of the basement membrane is believed to be a critical step in the metastatic process. Melanoma cells have been shown previously to bind distinct triple-helical regions within basement membrane (type IV) collagen. Additionally, tumor cell binding sites within type IV collagen contain glycosylated hydroxylysine residues. In the present study, we have utilized triple-helical models of the type IV collagen alpha1(IV)1263-1277 sequence to (a) determine the melanoma cell receptor for this ligand and (b) analyze the results of single-site glycosylation on melanoma cell recognition. Receptor identification was achieved by a combination of methods, including (a) cell adhesion and spreading assays using triple-helical alpha1(IV)1263-1277 and an Asp(1266)Abu variant, (b) inhibition of cell adhesion and spreading assays, and (c) triple-helical alpha1(IV)1263-1277 affinity chromatography with whole cell lysates and glycosaminoglycans. Triple-helical alpha1(IV)1263-1277 was bound by melanoma cell CD44/chondroitin sulfate proteoglycan receptors and not by the collagen-binding integrins or melanoma-associated proteoglycan. Melanoma cell adhesion to and spreading on the triple-helical alpha1(IV)1263-1277 sequence was then compared for glycosylated (replacement of Lys(1265) with Hyl(O-beta-d-galactopyranosyl)) versus non-glycosylated ligand. Glycosylation was found to strongly modulate both activities, as adhesion and spreading were dramatically decreased due to the presence of galactose. CD44/chondroitin sulfate proteoglycan did not bind to glycosylated alpha1(IV)1263-1277. Overall, this study (a) is the first demonstration of the prophylactic effects of glycosylation on tumor cell interaction with the basement membrane, (b) provides a rare example of an apparent unfavorable interaction between carbohydrates, and (c) suggests that sugars may mask "cryptic sites" accessible to tumor cells with cell surface or secreted glycosidase activities.
AuthorsJanelle L Lauer-Fields, Navdeep B Malkar, Gérard Richet, Karlheinz Drauz, Gregg B Fields
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 278 Issue 16 Pg. 14321-30 (Apr 18 2003) ISSN: 0021-9258 [Print] United States
PMID12574156 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Amino Acids
  • Carbazoles
  • Chondroitin Sulfate Proteoglycans
  • Collagen Type IV
  • Glycosaminoglycans
  • Hyaluronan Receptors
  • Ligands
  • Hydroxylysine
  • Aspartic Acid
  • Sodium Chloride
  • Lysine
Topics
  • Amino Acids (chemistry)
  • Aspartic Acid (chemistry)
  • Binding Sites
  • Carbazoles (chemistry)
  • Cell Adhesion
  • Chondroitin Sulfate Proteoglycans (metabolism)
  • Chromatography, High Pressure Liquid
  • Circular Dichroism
  • Collagen Type IV (metabolism)
  • Dose-Response Relationship, Drug
  • Enzyme-Linked Immunosorbent Assay
  • Glycosaminoglycans (metabolism)
  • Glycosylation
  • Humans
  • Hyaluronan Receptors (metabolism)
  • Hydroxylysine (metabolism)
  • Ligands
  • Lysine (chemistry)
  • Melanoma (metabolism)
  • Peptide Biosynthesis
  • Precipitin Tests
  • Protein Binding
  • Sodium Chloride (pharmacology)
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Temperature
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: